Skip to main content

and
  1. No Access

    Article

    Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse models

    Antiangiogenic therapy, specially sorafenib, has become the standard of care for patients with advanced hepatocellular carcinoma (HCC), however, the improvement in survival time is not satisfactory. Previous s...

    **ao-Dong Zhu, Hui-Chuan Sun, Hua-**ang Xu, Ling-Qun Kong, Zong-Tao Chai in Angiogenesis (2013)